Tumor Suppressor Proteins
"Tumor Suppressor Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.
Descriptor ID |
D025521
|
MeSH Number(s) |
D12.776.624.776
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tumor Suppressor Proteins".
Below are MeSH descriptors whose meaning is more specific than "Tumor Suppressor Proteins".
This graph shows the total number of publications written about "Tumor Suppressor Proteins" by people in this website by year, and whether "Tumor Suppressor Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 5 | 3 | 8 |
1996 | 3 | 5 | 8 |
1997 | 7 | 3 | 10 |
1998 | 18 | 8 | 26 |
1999 | 26 | 7 | 33 |
2000 | 9 | 7 | 16 |
2001 | 21 | 16 | 37 |
2002 | 19 | 16 | 35 |
2003 | 28 | 31 | 59 |
2004 | 23 | 48 | 71 |
2005 | 35 | 38 | 73 |
2006 | 29 | 13 | 42 |
2007 | 34 | 27 | 61 |
2008 | 39 | 15 | 54 |
2009 | 28 | 12 | 40 |
2010 | 32 | 27 | 59 |
2011 | 38 | 18 | 56 |
2012 | 32 | 15 | 47 |
2013 | 37 | 15 | 52 |
2014 | 24 | 18 | 42 |
2015 | 13 | 18 | 31 |
2016 | 23 | 13 | 36 |
2017 | 11 | 8 | 19 |
2018 | 16 | 8 | 24 |
2019 | 12 | 8 | 20 |
2020 | 14 | 7 | 21 |
2021 | 7 | 11 | 18 |
2022 | 3 | 10 | 13 |
2023 | 2 | 4 | 6 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Suppressor Proteins" by people in Profiles.
-
Acute leukemia of ambiguous lineage with BCL11B rearrangement. Blood. 2024 Jan 11; 143(2):183.
-
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results. Acta Neuropathol Commun. 2023 11 02; 11(1):175.
-
The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs. Cell Death Dis. 2023 05 22; 14(5):337.
-
The genomic landscape of familial glioma. Sci Adv. 2023 04 28; 9(17):eade2675.
-
Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree. Cell Death Dis. 2023 04 18; 14(4):274.
-
WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12. Prog Neurobiol. 2023 04; 223:102425.
-
Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort. Cancer Res. 2023 02 03; 83(3):386-397.
-
Expansion of the clinical and molecular spectrum of WWOX-related epileptic encephalopathy. Am J Med Genet A. 2023 03; 191(3):776-785.
-
MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer. Int J Mol Sci. 2022 Nov 23; 23(23).
-
Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. Circulation. 2022 11 29; 146(22):1694-1711.